日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling

通过转录组和基因谱分析挑战功能性高危骨髓瘤的概念

Beer, Sina A; Cairns, David A; Pawlyn, Charlotte; Holroyd, Amy; Ferris, Elsa; Cook, Gordon; Drayson, Mark; Boyd, Kevin; Proszek, Paula; Davies, Faith E; de Tute, Ruth; Jenner, Matthew; Morgan, Gareth J; Owen, Roger; Hubank, Michael; Houlston, Richard; Jackson, Graham; Kaiser, Martin F

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia

在针对华氏巨球蛋白血症的布鲁顿酪氨酸激酶抑制剂的3期ASPEN研究中,周围神经病变

Heyman, Benjamin M; Opat, Stephen S; Wahlin, Björn E; Dimopoulos, Meletios-Athanasios C; Castillo, Jorge J; Tedeschi, Alessandra; Tam, Constantine S; Buske, Christian; Owen, Roger G; Leblond, Véronique; Trotman, Judith; Barnes, Gisoo; Chan, Wai Y; Schneider, Jingjing; Allewelt, Heather; Cohen, Aileen; Matous, Jeffrey V

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

ASPEN 研究中,华氏巨球蛋白血症患者从伊布替尼过渡到泽布替尼后的疗效

García-Sanz, Ramón; Owen, Roger G; Jurczak, Wojciech; Dimopoulos, Meletios A; McCarthy, Helen; Cull, Gavin; Opat, Stephen S; Castillo, Jorge J; Kersten, Marie José; Wahlin, Björn E; Grosicki, Sebastian; Prathikanti, Radha; Tian, Tian; Allewelt, Heather; Cohen, Aileen Cleary; Tam, Constantine S

Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation.

MYC 的强制表达在浆细胞分化过程中指导着一种独特的转录状态

Vardaka Panagiota, Kemp Ben, Stephenson Sophie, Page Eden, Care Matthew A, Umpierrez Michelle, Annahar Adam, O'Callaghan Eleanor, Owen Roger, Hodson Daniel J, Doody Gina M, Tooze Reuben M

Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia

在R2W试验中,硼替佐米联合环磷酰胺和利妥昔单抗治疗华氏巨球蛋白血症,通过骨髓B细胞清除评估长期疗效

de Tute, Ruth; Counsell, Nicholas; Clifton-Hadley, Laura; D'Sa, Shirley; Pratt, Guy; Campbell, Gavin; Campbell, Lauren; Sadler, Ross; Townsend, William; Popova, Bilyana; Smith, Paul; Schofield, Oliver; Owen, Roger; Auer, Rebecca

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia

ASPEN 研究的生物标志物分析比较了泽布替尼和伊布替尼治疗华氏巨球蛋白血症患者的疗效

Tam, Constantine S; Opat, Stephen; D'Sa, Shirley; Jurczak, Wojciech; Lee, Hui-Peng; Cull, Gavin; Owen, Roger G; Marlton, Paula; Wahlin, Björn E; García-Sanz, Ramón; McCarthy, Helen; Mulligan, Stephen; Tedeschi, Alessandra; Castillo, Jorge J; Czyż, Jarosław; Fernández De Larrea, Carlos; Belada, David; Libby, Edward; Matous, Jeffrey; Motta, Marina; Siddiqi, Tanya; Tani, Monica; Trněný, Marek; Minnema, Monique C; Buske, Christian; Leblond, Véronique; Treon, Steven P; Trotman, Judith; Wu, Binghao; Yu, Yiling; Shen, Zhirong; Chan, Wai Y; Schneider, Jingjing; Allewelt, Heather; Cohen, Aileen; Dimopoulos, Meletios A

PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia

PembroWM:一项 II 期临床试验,旨在研究利妥昔单抗和帕博利珠单抗治疗复发/难治性华氏巨球蛋白血症的安全性和有效性。

Kothari, Jaimal; Eyre, Toby; Rismani, Ali; Ediriwickrema, Kushani; Edwards, Darren; Galani, Sevasti; Wilson, William; Lawrie, Anthony; Clifton-Hadley, Laura; McCarthy, Helen; Collins, Angela; Lewis, David; Arulogan, Suzanne; Auer, Rebecca; Pratt, Guy; de Tute, Ruth; Owen, Roger; D'Sa, Shirley

Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial

Waldenström巨球蛋白血症患者的健康相关生活质量:ASPEN试验结果

Tedeschi, Alessandra; Tam, Constantine S; Owen, Roger G; Buske, Christian; Leblond, Véronique; Dimopoulos, Meletios; Garcia-Sanz, Ramón; Castillo, Jorge J; Trotman, Judith; Treon, Steven P; Yang, Keri; Tang, Boxiong; Allewelt, Heather; Patel, Sheel; Chan, Wai Y; Cohen, Aileen; Chen, Shengnan; Barnes, Gisoo

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

扎那布替尼与伊布替尼治疗症状性华氏巨球蛋白血症:来自随机 III 期 ASPEN 研究的最终分析

Dimopoulos, Meletios A; Opat, Stephen; D'Sa, Shirley; Jurczak, Wojciech; Lee, Hui-Peng; Cull, Gavin; Owen, Roger G; Marlton, Paula; Wahlin, Björn E; Garcia-Sanz, Ramon; McCarthy, Helen; Mulligan, Stephen; Tedeschi, Alessandra; Castillo, Jorge J; Czyz, Jaroslaw; Fernández de Larrea, Carlos; Belada, David; Libby, Edward; Matous, Jeffrey; Motta, Marina; Siddiqi, Tanya; Tani, Monica; Trněný, Marek; Minnema, Monique C; Buske, Christian; Leblond, Veronique; Treon, Steven P; Trotman, Judith; Chan, Wai Y; Schneider, Jingjing; Allewelt, Heather; Patel, Sheel; Cohen, Aileen; Tam, Constantine S

Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial

通过扩展基因谱分析优化来那度胺维持治疗的价值:一项对 556 例骨髓瘤 XI 试验患者的分析

Panopoulou, Aikaterini; Cairns, David A; Holroyd, Amy; Nichols, Isabel; Cray, Nikita; Pawlyn, Charlotte; Cook, Gordon; Drayson, Mark; Boyd, Kevin; Davies, Faith E; Jenner, Matthew; Morgan, Gareth J; Owen, Roger; Houlston, Richard; Jackson, Graham; Kaiser, Martin F